Scientists in the laboratory of Rendong Yang, Ph.D., associate professor of Urology, have developed a new large language model that can interpret transcriptomic data in cancer cell lines more ...
Parse Biosciences introduces workflow for immune repertoire and transcriptome analysis: Seattle Saturday, January 24, 2026, 15:00 Hrs [IST] Parse Biosciences, the leading provider ...
The gene fusion testing market offers opportunities in developing advanced technologies like next-generation sequencing (NGS) ...
HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Researchers have revealed how patients with metastatic breast cancer develop resistance to Enhertu treatment.
In this interview, Technology Networks spoke to Dr. Funda Meric-Bernstam about the landscape of personalized cancer therapy.
Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a Centene company , has designated CommUnityCare Health Centers and Dell Children's Medical Group Primary Care ...
Phyx, a universal platform for selective sample enrichment, named finalist for the SLAS2026 New Product Award Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today ...
An exploratory study shows that combining short-term topical microdosing with gene-expression profiling can detect early drug activity in atopic dermatitis. Researchers observed disease-relevant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results